Vitamin D levels in patients with Behçet’s disease: Significance and impact on disease measures

Aim of the work This study aimed to investigate serum levels of vitamin D in patients with Behcet’s disease (BD) and to evaluate their relationship to disease activity as well as different disease measures. Patients and methods Forty-two patients with BD were enrolled into this study. These patients were subjected to detailed history taking, thorough clinical examination including assessment of disease activity according to Behcet’s Disease Current Activity Form (BDCAF) score and performed laboratory investigations including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), serum calcium, serum phosphorus and serum alkaline phosphatase. Serum 25-hydroxyvitamin D (vitamin D) levels were determined using Enzyme-Linked-Immunosorbent Assay (ELISA). A control group of 41 age and sex matched healthy controls was also included. Results The mean level of 25-hydroxyvitamin D (30.65 ± 12.87 ng/ml) was significantly decreased in BD patients compared to the controls (37.98 ± 15.76 ng/ml) ( p = 0.02). Significant negative correlations of serum vitamin D levels with patients’ ages ( p = 0.03), ESR ( p p p = 0.003) were found; whereas, there was no significant correlation with disease duration ( p = 0.6). In multivariate regression analysis age ( p = 0.02), colchicine therapy (0.008), ESR (0.02) and CRP (0.03) were found to be the independent effectors on vitamin D serum levels. Conclusion Serum levels of vitamin D were significantly lower in BD patients compared to controls. Associations were found between vitamin D levels and age, BDCAF as well as ESR and CRP in BD patients. Low vitamin D may predispose BD patients to active disease, especially in older subjects.